VIDEO: Blood-based panel detects early-stage liver cancer

BOSTON — In this exclusive video from The Liver Meeting 2019, Naga P. Chalasani, MD, from the Indiana University School of Medicine, discusses the accuracy of combined methylated DNA and protein markers for early-stage detection of hepatocellular carcinoma.“Hepatocellular carcinoma is the fourth most common cause of death worldwide and many patients present at a late stage and, thus, you cannot offer effective treatments,” Chalasani told Healio Gastroenterology and Liver Disease. “Currently, we use alpha-fetoprotein and ultrasound every 6 months [for screening];Read More

Share on facebook
Share on twitter
Share on linkedin